SBI Securities’s VanEck Biotech ETF BBH Stock Holding History

SBI Securities’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.2K	Hold	288	–	–	﹤0.01%	1067
2025 Q4	$54.5K	Sell	288 -30	-9%	-$5.55K	﹤0.01%	1047
2025 Q3	$52.7K	Sell	318 -114	-26%	-$18.6K	﹤0.01%	1070
2025 Q2	$66.2K	Buy	432 +1	+0.2%	+$149	﹤0.01%	951
2025 Q1	$67.8K	Sell	431 -85	-16%	-$13.8K	﹤0.01%	871
2024 Q4	$81K	Buy	+516	New	+$86.8K	﹤0.01%	824

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

SBI Securities's BBH Position: Q1 2026 in Review

SBI Securities held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 288 shares worth $54.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

SBI Securities first reported a position in BBH in Q4 2024 and has held it in 6 quarters since. The position peaked at $81K in Q4 2024. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

SBI Securities held 288 shares of VanEck Biotech ETF worth $54.2K as of Q1 2026.
SBI Securities left its VanEck Biotech ETF share count unchanged in Q1 2026.
VanEck Biotech ETF made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1067 holding.
SBI Securities first reported a position in VanEck Biotech ETF in Q4 2024 and has held it in 6 quarters since.
SBI Securities's VanEck Biotech ETF position peaked at $81K in Q4 2024.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.